MHH Logo

·   Structure / Regulations


Here you see the current structure of HBRS:

 structure (pdf file)





Hannover Biomedical Research School was founded in 2003. Since 2006, it has been supported in the course of the German Excellence Initiative (BMBF).

HBRS currently comprises of five international (MD)/PhD programs [“Molecular Medicine”, “Infection Biology”(& DEWIN: Dynamik der Erreger-Wirt Interaktionen), “Regenerative Sciences”, "Auditory Sciences" and "Epidemiology"], one DFG-funded international research training site together with the Karolinska Institue in Stockholm, Sweden and one Marie Curie Initial Training Site in the field of tissue engineering. All PhD programs are in English.
A structured doctoral program for medical students was also successfully established (StrucMed;, as well as two HBRS-associated Master programs “Biomedicine” (start October 2007) and “Biochemistry” (start October 2008).

In 2011, MHH and partner institutes have founded the "Voluntary Research Year" for high school graduates. (more info)


Currently, the various programs of HBRS host ~280 PhD students. In addition, ~40 medical students were accepted for StrucMed, 11 students start the new KlinStrucMed program as well as 60 new Master students (in two programs) will start this year. There are about 50% international and around 25% medical doctors doing their PhD (~50% women).


International Advisory Board (IAB):

currently Michael Carroll (Harvard Medical School, Boston, USA), Joachim R. Kalden (University of Erlangen, Germany), Steve Keyse (University of Dundee, UK), Nathalie Cartier (INSERM, Fontanay aux Roses, France), Hans-Gustaf Ljunggren (Karolinska Institute, Stockholm, Sweden), Seppo Meri (University of Helsinki, Finland), Alfred Nordheim (University of Tübingen, Germany), Stanislas Pol (University Hospital Paris, France)




Rules and Regulations

You may find details about the organs of HBRS in the HBRS rules (see section "Rules and Regulations").